Get 40% Off
🤯 This Tech Portfolio is up 29% YTD! Join Now to Get April’s Top PicksGet The Picks – Just 99 USD

UK and South Korea agree COVID-19 vaccine swap deal

Published 22/09/2021, 10:17
Updated 22/09/2021, 10:21
© Reuters. FILE PHOTO: Nurse Grenda Mzizi prepares a dose of Pfizer vaccine against COVID-19 at a vaccination centre in Pharmacy 4 U, amid the outbreak of the coronavirus disease (COVID-19), in Blackburn, Britain, May 19, 2021. REUTERS/Jason Cairnduff

© Reuters. FILE PHOTO: Nurse Grenda Mzizi prepares a dose of Pfizer vaccine against COVID-19 at a vaccination centre in Pharmacy 4 U, amid the outbreak of the coronavirus disease (COVID-19), in Blackburn, Britain, May 19, 2021. REUTERS/Jason Cairnduff

LONDON (Reuters) - Britain and South Korea have agreed to swap over 1 million COVID-19 vaccine doses with each other, with the UK sending a first batch of Pfizer (NYSE:PFE) shots in the coming weeks and Korea returning the same volume by the end of the year.

© Reuters. FILE PHOTO: Nurse Grenda Mzizi prepares a dose of Pfizer vaccine against COVID-19 at a vaccination centre in Pharmacy 4 U, amid the outbreak of the coronavirus disease (COVID-19), in Blackburn, Britain, May 19, 2021. REUTERS/Jason Cairnduff

Britain said it would send Pfizer doses which it does not immediately need, so they can be used more quickly in South Korea.

"By working closely with our friends in South Korea, this vaccine swap will maximise their rollout speed without having an impact on the UK's vaccine programme," health minister Sajid Javid said in a statement.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.